» Articles » PMID: 19010987

Evolution of MicroRNA Expression During Human Bronchial Squamous Carcinogenesis

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2008 Nov 18
PMID 19010987
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs, negative post-transcriptional regulators of gene expression, are involved in cancer. Their role in early bronchial carcinogenesis was analysed in 60 biopsies obtained by fluorescence bronchoscopy (six per stage: normal tissue of nonsmokers, normal normofluorescent and hypofluorescent bronchial tissue of smokers, hyperplasia, metaplasia, mild, moderate and severe dysplasia, in situ carcinoma and invasive squamous cell carcinoma (SQCC)). In total, 69 microRNAs were found to be differentially expressed in the course of bronchial carcinogenesis. Among them, some microRNAs showed a linear evolution of their expression level, such as miR-32 and miR-34c, whose expression progressively decreased from normal bronchial tissues of nonsmokers to SQCC. Others behaved differently at successive stages, such as miR-142-3p or miR-9, or are only altered from a specific stage, such as miR-199a or miR-139. MicroRNAs globally followed a two-step evolution, first decreasing (a reverse of their increase during embryogenesis) during the earliest morphological modifications of bronchial epithelium, and thereafter increasing at later stages of lung carcinogenesis. Moreover, microRNA expression was very efficient for the prediction of the histological classification between low- and high-grade lesions and between in situ and invasive carcinoma. The present data show, for the first time, that microRNAs are involved in bronchial carcinogenesis from the very early steps of this process and, thus, could provide tools for early detection of lung cancer.

Citing Articles

Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement.

Moghaddam S, Savai R, Salehi-Rad R, Sengupta S, Kammer M, Massion P Am J Respir Crit Care Med. 2024; 210(5):548-571.

PMID: 39115548 PMC: 11389570. DOI: 10.1164/rccm.202406-1168ST.


Tumor suppressor PTEN regulation by tobacco smoke in lung squamous-cell carcinoma based on bioinformatics analysis.

Pustylnyak V, Alekseenok E, Perevalova A, Kozlov V, Gulyaeva L Heliyon. 2023; 9(8):e19044.

PMID: 37609416 PMC: 10440530. DOI: 10.1016/j.heliyon.2023.e19044.


Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis.

Mei Q, Liu Z, Zuo H, Yang Z, Qu J Front Pharmacol. 2022; 12:797292.

PMID: 35126134 PMC: 8807692. DOI: 10.3389/fphar.2021.797292.


Evasion before invasion: Pre-cancer immunosurveillance.

Angelova M, Mascaux C, Galon J Oncoimmunology. 2021; 10(1):1912250.

PMID: 33996263 PMC: 8078715. DOI: 10.1080/2162402X.2021.1912250.


Epigenetic silencing of microRNA-199a-5p promotes the proliferation of non-small cell lung cancer cells by increasing AKAP1 expression.

Yang N, Liang Y, Zhu T, Long Y, Chen Z, Zhang X Oncol Lett. 2021; 21(6):434.

PMID: 33868472 PMC: 8045157. DOI: 10.3892/ol.2021.12695.